PCI vs. CABG in patients aged under 50 years

Original title: Comparison of 30-Day and 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Bypass Grafting in Patients Aged ≤50 Years.  Reference: Fausto Biancari, et al. Am J Cardiology Article in Press.

 

Coronary artery bypass grafting (CABG) is associated with better evolution than percutaneous coronary intervention (PCI), mainly due to left main and multiple vessels re interventions. In ≤50 year old patients, results have not been thoroughly analyzed.

This retrospective analysis included 1617 patients receiving PCI and 592 receiving CABG for multiple vessels disease or left main lesions. Diabetes, renal failure, peripheral vascular disease, severe left main lesion, previous intervention and severe ventricular dysfunction occurred more often in the CABG group.

After propensity score matching, given the different baseline characteristics, 235 patients remained for final analysis. Immediate evolution, late mortality and freedom from cerebrovascular events at 5 years were similar in both groups. 

On the other hand, PCI patients presented lower freedom form revascularization and myocardial infarction. Among diabetics, global mortality was also similar in PCI and CABG groups but with greater chances of infarction, revascularization and stroke in the PCI group. 

STEMI patients receiving PCI presented a higher survival rate at 5 years, driven by its lower 30 day mortality rate (6% vs 1.5%; p=0.017). Freedom from combined events in this last group was similar. PCI was associated with repeat revascularization.

Conclusion

≤50 year patients have excellent immediate evolution with both PCI and CABG. At 5 years, PCI was associated with a significantly higher rate of infarction or repeat revascularization. 

Commentary

This analysis shows that evolution at 5 years with PCI or CABG is similar in terms or mortality. PCI is associated with higher rates of repeat revascularization and non-fatal AMI, as the large randomized studies show. In patients presenting with STEMI, PCI was superior to CABG in terms of mortality, which offers an advantage.

Carlos Fava

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...